What is the official website of Alembic Pharmaceuticals Limited ?

The official website of Alembic Pharmaceuticals Limited is http://www.alembic-india.com.

What is Alembic Pharmaceuticals Limited's cybersecurity risk score?

Alembic Pharmaceuticals Limited has an AI-generated cybersecurity risk score of 759 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Alembic Pharmaceuticals Limited experienced?

According to Rankiteo, Alembic Pharmaceuticals Limited currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Alembic Pharmaceuticals Limited been affected by any supply chain cyber incidents ?

According to Rankiteo, Alembic Pharmaceuticals Limited has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Alembic Pharmaceuticals Limited have SOC 2 Type 1 certification ?

According to Rankiteo, Alembic Pharmaceuticals Limited is not certified under SOC 2 Type 1.

Does Alembic Pharmaceuticals Limited have SOC 2 Type 2 certification ?

According to Rankiteo, Alembic Pharmaceuticals Limited does not hold a SOC 2 Type 2 certification.

Does Alembic Pharmaceuticals Limited comply with GDPR ?

According to Rankiteo, Alembic Pharmaceuticals Limited is not listed as GDPR compliant.

Does Alembic Pharmaceuticals Limited have PCI DSS certification ?

According to Rankiteo, Alembic Pharmaceuticals Limited does not currently maintain PCI DSS compliance.

Does Alembic Pharmaceuticals Limited comply with HIPAA ?

According to Rankiteo, Alembic Pharmaceuticals Limited is not compliant with HIPAA regulations.

Does Alembic Pharmaceuticals Limited have ISO 27001 certification ?

According to Rankiteo,Alembic Pharmaceuticals Limited is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Alembic Pharmaceuticals Limited operate in ?

Alembic Pharmaceuticals Limited operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Alembic Pharmaceuticals Limited have ?

Alembic Pharmaceuticals Limited employs approximately 14,168 people worldwide.

Does Alembic Pharmaceuticals Limited own any subsidiaries ?

Alembic Pharmaceuticals Limited presently has no subsidiaries across any sectors.

How many LinkedIn followers does Alembic Pharmaceuticals Limited have ?

Alembic Pharmaceuticals Limited's official LinkedIn profile has approximately 410,101 followers.

What is the NAICS classification code for Alembic Pharmaceuticals Limited ?

Alembic Pharmaceuticals Limited is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does Alembic Pharmaceuticals Limited have a Crunchbase profile ?

No, Alembic Pharmaceuticals Limited does not have a profile on Crunchbase.

Does Alembic Pharmaceuticals Limited have a LinkedIn profile ?

Yes, Alembic Pharmaceuticals Limited maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/alembic.

How many cybersecurity incidents has Alembic Pharmaceuticals Limited experienced ?

As of September 20, 2026, Rankiteo reports that Alembic Pharmaceuticals Limited has not experienced any cybersecurity incidents.

How many peer or competitor companies does Alembic Pharmaceuticals Limited have ?

Alembic Pharmaceuticals Limited has an estimated 5,767 peer or competitor companies worldwide.

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

APL

Boost Score +25 with badge (5 left)

759

/1000

Fair

784

/1000

Fair

Alembic Pharmaceuticals Limited Vendor Cyber Rating & Cyber Score

alembic-india.com

Add Your Compliance Badge

Established in 1907, Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates. Alembic is the market leader in the Macrolides segment of anti-infective drugs in India. Alembic's manufacturing facilities are located in Vadodara and Baddi in Himachal Pradesh. The plant at Vadodara has the largest fermentation capacity in India. The Panelav facility houses the API and formulation manufacturing (both US FDA approved) plants. The plant at Baddi, Himachal Pradesh manufactures formulations for the domestic and non-regulated export market. The company has a state of

APL

Alembic Pharmaceuticals Limited CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

APL Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for APL

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Alembic Pharmaceuticals Limited in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Alembic Pharmaceuticals Limited in 2026.

Incident Types APL vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Alembic Pharmaceuticals Limited in 2026.

Incident History - APL (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Alembic Pharmaceuticals Limited Subsidiaries

Parent Company

APL

Pharmaceutical Manufacturing

Website: http://www.alembic-india.com

Company Size: 5,001-10,000 employees

No subsidiary data available for this company.

Loading…

Alembic Pharmaceuticals Limited Similar Companies

Johnson & Johnson Innovative Medicine

jnj.com

At Johnson & Johnson Innovative Medicine, we innovate with purpose, to lead where medicine is going. The experiences of patients around the world inform and inspire our science-based innovations, which continue to change and save lives. Applying rigorous science with compassion, we confidently address the most complex diseases of our time and develop the potential medicines of tomorrow. We are continuously working to develop treatments, aspiring to find cures, pioneering the path from lab to life, and championing patients every step of the way. https://bit.ly/3reuMvK

Novartis

novartis.com

Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki

Astellas Pharma

astellas.com

Astellas is a global life sciences company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and development programs, we are pioneering new healthcare solutions for diseases with high unmet medical need. Visit our Global Astellas LinkedIn Community Guidelines to learn more about interacting with this page: https://www.astellas.com/en/global-linkedin-community-guidelines

Torrent Pharmaceuticals Ltd

cb torrentpharma.com

Torrent Pharma, with annual revenues of more than Rs 10,700 crores, is the flagship Company of the Torrent Group, with group revenues of Rs 41,000 crores. It is ranked 5th in the Indian Pharma Market and is among the Top 5 in the therapeutic segments of Cardiovascular (CV), Central Nervous System (CNS), Gastro-intestinal (GI), Vitamins Minerals Nutritionals (VMN) and Cosmo-Dermatology. The Company also has significant presence in diabetology, pain management, gynaecology, oncology and anti-infective segments. Torrent has 8 manufacturing facilities , of which 5 are USFDA approved. With R&D as the backbone for its growth in domestic & overseas market, it has invested significantly in R&D capabilities with state-of-the-art R&D infrastructure employing around 800 scientists. The acquisition of Elder Pharma's Indian branded business in 2013, Dermaceuticals business of Zyg Pharma in 2015, API plant of Glochem Industries in 2016, Women healthcare brands from Novartis and Unichem's Indian branded business along with its Sikkim Plant in 2017 strengthened Torrent Pharma's position in the Indian Pharma market. Torrent Pharma started international acquisitions in 2005 with entry into the German market. Today, the Company has presence in more than 50 countries and is ranked No. 1 among the Indian pharma Companies in Brazil and Germany. Torrent Pharma is committed towards “not just healthcare but lifecare.”

Zydus Group

zyduslife.com

The Zydus Group with an overarching purpose of empowering people with freedom to live healthier and more fulfilled lives, is an innovative, global life-sciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies. The group employs over 27000 people worldwide and is driven by its mission to unlock new possibilities in life-sciences through quality healthcare solutions that impact lives. The group aspires to transform lives through pathbreaking discoveries.

AUROBINDO PHARMA LTD

aurobindo.com

Aurobindo Pharma Limited (NSE: AUROPHARMA, BSE: 524804, Reuters: ARBN.NS, Bloomberg: ARBP IN) is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and markets a wide range of generic pharmaceuticals, branded specialty drugs, and active pharmaceutical ingredients (APIs) across more than 150 countries. It is ranked among the top 10 generic companies in eight European nations and holds the distinction of being the largest generic pharmaceutical company in the United States. With over 30 state-of-the-art manufacturing and packaging facilities approved by leading global regulatory authorities including USFDA, UK MHRA, EDQM, Japan PMDA, WHO, Health Canada, South Africa MCC, and Brazil ANVISA, Aurobindo Pharma ensures the highest standards of quality. Its robust portfolio spans eight major therapeutic areas: Central Nervous System (CNS), Antiretroviral (ARV), Cardiovascular (CVS), Antibiotics, Gastroenterology, Anti-diabetics, Oncology, and Dermatology, supported by a strong R&D infrastructure that drives innovation, affordability, and accessibility.

Servier

servier.com

Founded to serve health 70 years ago, Servier is a global pharmaceutical group governed by a non-profit Foundation that aspires to make a meaningful social impact for patients and for a sustainable world. The Group’s unique governance model preserves its independence and means it can fully serve its vocation of being committed to therapeutic progress to serve patient needs while adopting a long-term vision. Its employees are fully committed to this shared vocation, which serves as a source of inspiration every day. A world leader in cardiometabolism and venous diseases, Servier has made a major shift into oncology, which represents a new pillar of strategic growth. The Group devotes close to 70% of its R&D budget to this field, with the ambition of becoming a focused and innovative player in the development of treatments targeting rare cancers. Neurology will constitute a future growth driver. Servier is focusing on a limited number of diseases in this area where accurate patient profiling makes it possible to offer a targeted therapeutic response through precision medicine. To promote widespread access to quality care at a lower cost, the Group also offers a range of quality generic drugs covering most pathologies, leveraging well-known brands in France, and Eastern Europe. In all these areas, the Group takes patient considerations into account at every stage of the medicine life cycle. Headquartered in France, Servier relies on committed teams and strong geographical footprint; its medicines are available in close to 140 countries. In 2023/2024, the Group achieved sales revenue of €5.9 billion and EBITDA of €1.3 billion in 2024 (22.2%). Today, the Group employs over 22,000 people worldwide. -- To report a suspected adverse event with a Servier drug, please visit servier.com

AbbVie

cb abbvie.com

AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, aesthetics and other areas of unmet need. Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html.

Novo Nordisk

cb novonordisk.com

We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 68,800 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com. This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to block and remove those that are off-topic, abusive or intended to spam. Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in: https://www.novonordisk.com/contact-us/find-local-information.html For other customer complaints, please contact us here: https://www.novonordisk.com/contact-us.html Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed. Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users. Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html

Loading…

NEWS

Alembic Pharmaceuticals Limited CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

January 07, 2022 08:40 PM

Alembic Pharmaceuticals Share Price Today - Alembic Pharmaceuticals Stock Price Live NSE/BSE

Alembic Pharmaceuticals Share Price - Get live BSE/NSE Alembic Pharmaceuticals share price with latest research reports, balance sheet, stock analysis...

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-94057

SUMMARY

Exim before 4.100.1 allows SMTP smuggling in which the received message does not match any sent message, and instead depends on crafted data sent after a rejection during DATA processing.

Published

Date2026-09-19

Updated

Date2026-09-19

RISK INFORMATION (Score: 4)

cvss3

Base Score: 4.0

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:C/C:N/I:L/A:N

Impact Score

1.4

Exploitability

2.2

REFERENCES

https://lists.exim.org/lurker/message/20260918.121220.0f87338e.en.html

CVE-2026-94056

SUMMARY

Exim before 4.100.1, when Proxy-Protocol is used with an attacker-controlled proxy, allows attackers to read certain uninitialized data from stack memory.

Published

Date2026-09-19

Updated

Date2026-09-19

RISK INFORMATION (Score: 7.5)

cvss3

Base Score: 7.5

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:C/C:H/I:N/A:L

Impact Score

4.7

Exploitability

2.2

REFERENCES

https://lists.exim.org/lurker/message/20260918.121220.0f87338e.en.html

CVE-2026-94055

SUMMARY

Exim before 4.100.1, when certain non-default TLS settings are used with GnuTLS, has a use-after-free.

Published

Date2026-09-19

Updated

Date2026-09-19

RISK INFORMATION (Score: 3.7)

cvss3

Base Score: 3.7

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:N/I:N/A:L

Impact Score

1.4

Exploitability

2.2

REFERENCES

https://lists.exim.org/lurker/message/20260918.121220.0f87338e.en.html

CVE-2026-94054

SUMMARY

Exim before 4.100.1, when Proxy-Protocol is used with an attacker-controlled proxy, has an out-of-bounds write.

Published

Date2026-09-19

Updated

Date2026-09-19

RISK INFORMATION (Score: 7)

cvss3

Base Score: 7.0

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:L/I:H/A:L

Impact Score

4.7

Exploitability

2.2

REFERENCES

https://lists.exim.org/lurker/message/20260918.121220.0f87338e.en.html

CVE-2026-93993

SUMMARY

Mistral Vibe before 2.25.5 contains a remote code execution vulnerability in the worktree creation process that executes git hooks before trust validation. Attackers can supply a repository with a crafted post-checkout hook that executes arbitrary shell commands with the privileges of the user running Vibe.

Published

Date2026-09-19

Updated

Date2026-09-19

RISK INFORMATION (Score: 8.8)

cvss3

Base Score: 8.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H

cvss4

Base Score: 8.6

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:A/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

5.9

Exploitability

2.8

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…

Badge your company to reduce your risk score and your cyber insurance costs!

Trusted by insurers. Chosen by leaders.

Alembic Pharmaceuticals Limited Vendor Cyber Rating & Cyber Score

APL A.I CyberSecurity Scoring

Alembic Pharmaceuticals Limited CyberSecurity News & History

APL Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for APL

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types APL vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - APL (X = Date, Y = Severity)

Alembic Pharmaceuticals Limited Subsidiaries

Parent Company

APL

Alembic Pharmaceuticals Limited Similar Companies

Johnson & Johnson Innovative Medicine

Novartis

Astellas Pharma

Torrent Pharmaceuticals Ltd

Zydus Group

AUROBINDO PHARMA LTD

Servier

AbbVie

Novo Nordisk

Alembic Pharmaceuticals Limited CyberSecurity News

Alembic Pharmaceuticals Share Price Today - Alembic Pharmaceuticals Stock Price Live NSE/BSE

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo

Alembic Pharmaceuticals Limited CyberSecurity News & History

APL Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for APL

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types APL vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - APL (X = Date, Y = Severity)

Alembic Pharmaceuticals Limited Subsidiaries

Parent Company

APL

Alembic Pharmaceuticals Limited Similar Companies

Johnson & Johnson Innovative Medicine

Novartis

Astellas Pharma

Torrent Pharmaceuticals Ltd

Zydus Group

AUROBINDO PHARMA LTD

Servier

AbbVie

Novo Nordisk

Alembic Pharmaceuticals Limited CyberSecurity News

Alembic Pharmaceuticals Share Price Today - Alembic Pharmaceuticals Stock Price Live NSE/BSE

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo